Publications (531) Felipe Prosper Cardoso publications View referenced research data.

filter_list

2025

  1. 3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

    Journal of Visualized Experiments, Vol. 2025-March, Núm. 217

  2. 3D-printed polycaprolactone scaffolds functionalized with poly(lactic-co-glycolic) acid microparticles enhance bone regeneration through tunable drug release

    Acta Biomaterialia, Vol. 198, pp. 219-233

  3. Airway basal stem cells are necessary for the maintenance of functional intraepithelial airway macrophages

    Cell Reports, Vol. 44, Núm. 6

  4. Aptameroak Mieloma Anizkoitzaren aurkako RNA-n oinarritutako terapien garapenerako

    Osasun Zientziak: VI. Ikergazte Nazioarteko Ikerketa Euskaraz. : 2025eko maitzaren 28, 29 eta 30 Bilbo, Euskal Herria.

  5. BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1

    Haematologica

  6. Billion-Scale Expansion of Functional hiPSC-Derived Cardiomyocytes in Bioreactors Through Oxygen Control and Continuous Wnt Activation

    Advanced Science

  7. Biologically-Inspired Melt Electrowriting for the Generation of Highly Biomimetic Functional Myocardium

    Advanced Functional Materials, Vol. 35, Núm. 33

  8. Chaperone-mediated autophagy sustains pericyte stemness necessary for brain tissue homeostasis

    Journal of Advanced Research

  9. Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy

    American Journal of Hematology, Vol. 100, Núm. 1, pp. 93-102

  10. Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors

    Molecular Cancer, Vol. 24, Núm. 1

  11. Continuous map of early hematopoietic stem cell differentiation across human lifetime

    Nature Communications , Vol. 16, Núm. 1

  12. Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML

    Molecular Therapy Oncology, Vol. 33, Núm. 1

  13. Effect of Hyaluronic Acid Compared to Platelet-Rich Plasma as Adjuvants to Bone Marrow Mesenchymal Stem Cell Treatment of Knee Osteoarthritis: Analysis from Two Clinical Trials

    Diagnostics, Vol. 15, Núm. 3

  14. Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma (Journal of Clinical Oncology (2025) DOI: 10.1200/JCO-24-01893)

    Journal of Clinical Oncology

  15. Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma

    Blood, Vol. 145, Núm. 2, pp. 202-219

  16. From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis

    Cancers, Vol. 17, Núm. 11

  17. Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances

    Molecular Therapy Methods and Clinical Development, Vol. 33, Núm. 1

  18. Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments

    Human Gene Therapy

  19. Implication of bone marrow adipose tissue in bone homeostasis during osteoarthritis

    Osteoarthritis and Cartilage, Vol. 33, Núm. 8, pp. 951-964

  20. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

    Journal of Clinical Oncology, Vol. 43, Núm. 24, pp. 2739-2751